StockViz
RANKINGS
Qiagen N.V.
NYSE:QGEN
Sector
Location
Market Cap
USD 10.44 B
Share Price
USD 48.21
Avg Daily Volume
1,514,744
Change (1 day)
0.31%
Change (1 year)
19.84%
Change (YTD)
8.26%
Qiagen N.V. Income Statement 2015 - 2025
This table shows the Income Statement for Qiagen N.V. going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
Abbott Laboratories
USD 136.26
ABT
+0.25
0.18%
Boston Scientific Corporation
USD 104.78
BSX
-2.63
-2.45%
Thermo Fisher Scientific Inc.
USD 421.47
TMO
+16.01
3.95%
Siemens Healthineers AG
USD 55.39
SHL.DE
-0.08
-0.14%
Becton, Dickinson and Company
USD 177.67
BDX
+5.42
3.15%
GE HealthCare Technologies Inc.
USD 75.95
GEHC
+1.88
2.54%
Agilent Technologies, Inc.
USD 120.45
A
+2.44
2.07%
Natera, Inc.
USD 160.72
NTRA
-8.22
-4.87%
Laboratory Corporation of America Holdings
USD 264.26
LH
+1.75
0.67%
bioMérieux S.A.
USD 138.48
BIM.PA
+0.11
0.08%
Baxter International Inc.
USD 31.23
BAX
+0.95
3.14%
Revvity, Inc.
USD 99.03
RVTY
+2.31
2.39%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.50
603392.SS
+0.10
1.18%
Exact Sciences Corporation
USD 54.60
EXAS
+1.46
2.75%
ConvaTec Group Plc
USD 3.74
CTEC.L
-0.22
-5.61%
Globus Medical, Inc.
USD 60.20
GMED
+1.18
2.00%
Bio-Rad Laboratories, Inc.
USD 247.99
BIO
+6.67
2.76%
Bruker Corporation
USD 41.90
BRKR
+0.70
1.70%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.76
300832.SZ
-0.12
-1.49%